GO:0006414 translational elongation: Protein Synthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006414 translational elongation is the successive addition of amino acid residues to a nascent polypeptide chain during protein biosynthesis.
• Elongation is driven by conserved GTP-hydrolyzing factors, including EF-Tu/eEF1A and EF-G/eEF2, that couple nucleotide hydrolysis to ribosome motion.
• Ribosome profiling at nucleotide resolution revealed that elongation speed varies along transcripts and influences mRNA stability and protein output [3,4].
• Single-molecule imaging showed that elongation is a dynamic, stochastic process that can be modulated by mRNA localization and stress [6,7].
• Elongation is coupled to quality-control pathways, including ubiquitylation-dependent resolution of RNA-protein crosslinks.
• Dysregulated elongation is linked to cancer, neurodegeneration, and ribosomopathies, making it a target for therapeutic and CRISPR-based studies [1,3].
Description
Translational elongation (GO:0006414) is the central phase of protein biosynthesis in which amino acids are sequentially added to a growing polypeptide chain on the ribosome. It is a highly conserved process that consumes GTP and requires coordinated action of ribosomal RNA, elongation factors, and aminoacyl-tRNAs [2,5]. Because elongation determines the rate and fidelity of protein production, it is a focal point for understanding gene expression, cellular stress responses, and disease mechanisms [1,3]. Researchers study translational elongation to dissect how cells regulate proteostasis, respond to stress, and maintain mRNA stability [3,6]. Advances in ribosome profiling and single-molecule imaging have provided nucleotide-resolution and real-time views of elongation dynamics in vivo [4,7]. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0006414, its molecular players, and experimental approaches.
translational elongation At A Glance
| GO ID | GO:0006414 |
|---|---|
| GO term | translational elongation |
| Ontology | biological_process |
| Synonym | protein synthesis elongation; translation elongation |
| Major function | Successive addition of amino acid residues to a nascent polypeptide chain during protein biosynthesis |
| Cellular location | Ribosome (cytoplasm in eukaryotes; 70S ribosome in prokaryotes) |
| Key factors | Elongation factors (EF-Tu, EF-G, eEF1A, eEF2), aminoacyl-tRNAs, GTP |
| Energy requirement | GTP hydrolysis for factor recycling and translocation |
| Related processes | Translation initiation, termination, co-translational folding, mRNA stability |
What Is GO:0006414?
According to the Gene Ontology, GO:0006414 translational elongation is defined as the successive addition of amino acid residues to a nascent polypeptide chain during protein biosynthesis. It is a biological process that encompasses the cyclic steps of codon recognition, peptide bond formation, and translocation on the ribosome, ensuring processive synthesis of proteins [1,5].
Why Is translational elongation Important in Cell Biology?
Translational elongation is a fundamental determinant of protein expression and cellular homeostasis, and its dysregulation is implicated in a broad spectrum of human diseases, including cancer, neurodegeneration, and ribosomopathies [1,3]. Because elongation rates influence co-translational folding and mRNA stability, it serves as a critical node linking genotype to phenotype [1,3]. Understanding its mechanisms provides opportunities for therapeutic intervention and for interpreting the effects of genetic variants [2,8].
• Controls the rate and fidelity of protein synthesis, impacting proteome composition.
• Couples translation to mRNA stability via codon optimality.
• Influences co-translational protein folding and targeting.
• Is a target of natural antibiotics and potential therapeutics.
• Dysregulation is linked to cancer and neurodegeneration [1,3].
• Plays a role in stress granule biology and stress responses.
• Is modulated by quality-control pathways that resolve RNA-protein crosslinks.
• Can be studied at nucleotide resolution using ribosome profiling.
• Single-molecule imaging reveals dynamic regulation in live cells.
• Provides a paradigm for understanding GTP-driven molecular machines.
What Happens During translational elongation?
Codon recognition and aminoacyl-tRNA delivery
In simple terms: The ribosome reads the next three letters of the genetic message and brings in the matching amino acid.
During elongation, a ternary complex of elongation factor Tu (EF-Tu in bacteria; eEF1A in eukaryotes), GTP, and aminoacyl-tRNA delivers the correct aminoacyl-tRNA to the ribosomal A site [1,2]. Codon-anticodon pairing triggers GTP hydrolysis and conformational changes that ensure fidelity. This step is rate-limiting and is influenced by codon optimality, which can affect mRNA stability.
Peptide bond formation
In simple terms: The new amino acid is stitched onto the growing protein chain.
The peptidyl transferase center of the large ribosomal subunit catalyzes peptide bond formation between the peptidyl-tRNA in the P site and the aminoacyl-tRNA in the A site. This reaction is intrinsic to the ribosome and does not require additional energy beyond that used in tRNA delivery.
Translocation and ribosome movement
In simple terms: The ribosome shifts forward by one codon to make room for the next amino acid.
Elongation factor G (EF-G in bacteria; eEF2 in eukaryotes) catalyzes translocation, moving the mRNA and tRNAs by one codon and converting GTP hydrolysis into mechanical motion. This step is highly conserved and is a target of antibiotics such as fusidic acid.
Elongation cycle and processivity
In simple terms: The ribosome repeats the same three steps over and over to build the full protein.
The elongation cycle repeats for each codon, with EF-Tu and EF-G recycling through GTP-bound states [1,2]. The overall rate of elongation varies across transcripts and can be modulated by mRNA structure, codon usage, and trans-acting factors [3,4].
Coupling to co-translational folding and quality control
In simple terms: As the protein is made, it starts to fold and is checked for errors.
Nascent polypeptides can fold co-translationally, and elongation rates influence folding pathways and targeting to membranes. Quality-control pathways, including ubiquitylation, can resolve RNA-protein crosslinks that stall elongation.
Key Genes Involved in GO:0006414 translational elongation
The following genes and proteins are central to translational elongation, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EEF1A1 | Eukaryotic elongation factor 1A; delivers aminoacyl-tRNA to the ribosome | Target for studying codon optimality and cancer [1,3] |
| EEF2 | Eukaryotic elongation factor 2; catalyzes translocation | Target of antibiotics and regulator of elongation rate |
| RPL3 | Ribosomal protein L3; component of the large subunit | Mutations linked to ribosomopathies |
| RPS19 | Ribosomal protein S19; component of the small subunit | Associated with Diamond-Blackfan anemia |
| TUFM | Mitochondrial elongation factor Tu | Involved in mitochondrial translation |
| GFM1 | Mitochondrial elongation factor G1 | Mutations cause mitochondrial disease |
| RACK1 | Ribosome-associated scaffold protein | Modulates translation and stress responses |
| DDX3X | RNA helicase involved in translation | Linked to cancer and neurodevelopment |
| RNF14 | E3 ubiquitin ligase | Promotes resolution of RNA-protein crosslinks during elongation |
| EIF4E | Cap-binding protein; affects translation initiation and elongation coupling | Target in cancer therapy |
| EIF4G | Scaffold for initiation complex | Integrates translation with cell growth |
| PABPC1 | Poly(A)-binding protein; influences mRNA stability and translation | Linked to codon optimality effects |
| NCL | Nucleolin; ribosome biogenesis and translation | Marker in cancer |
| HNRNPK | RNA-binding protein; modulates translation | Implicated in stress granule biology |
| UPF1 | Nonsense-mediated decay factor; interacts with elongation | Couples translation to mRNA quality control |
| GCN2 | Stress kinase; phosphorylates eIF2α | Regulates translation under stress |
| MTOR | Kinase regulating translation via 4E-BP and S6K | Central to growth control |
How Is translational elongation Regulated?
Translational elongation is regulated at multiple levels. Codon optimality influences elongation speed and mRNA stability, linking elongation to transcript fate. Stress-responsive kinases such as GCN2 can phosphorylate eIF2α, indirectly affecting elongation dynamics. The mTOR pathway controls translation capacity by regulating initiation factors and ribosomal biogenesis, which in turn impacts elongation. Quality-control ubiquitylation by RNF14 resolves stalled elongation complexes caused by RNA-protein crosslinks. Additionally, single-molecule studies have revealed that mRNA localization and stress granule association can modulate elongation in live cells [6,7].
translational elongation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EEF1A1 | Cancer; oncogenic translation | Knockout and overexpression in cancer cell lines |
| EEF2 | Cancer; translation inhibition | Point mutation of GTP-binding domain |
| RPS19 | Diamond-Blackfan anemia | Knock-in of patient mutations in hematopoietic cells |
| GFM1 | Mitochondrial disease | Knockout in patient-derived fibroblasts |
| RNF14 | RNA-protein crosslink repair; stress response | Knockout and tagged knock-in for imaging |
Cancer
Dysregulated translational elongation supports oncogenic protein synthesis and is a hallmark of many cancers [1,3]. Codon optimality-mediated mRNA degradation can influence the expression of oncogenes and tumor suppressors. Targeting elongation factors such as eEF1A and eEF2 is an active area of therapeutic development.
Neurodegeneration
Impaired elongation and ribosome stalling contribute to neurodegeneration by disrupting proteostasis [1,6]. Stress granule formation, which can sequester elongation components, is linked to neurodegenerative diseases. Single-molecule imaging has shown that translation of mRNAs localized to stress granules is dynamically regulated.
Ribosomopathies
Mutations in ribosomal proteins and elongation factors cause ribosomopathies such as Diamond-Blackfan anemia and Shwachman-Diamond syndrome. These disorders highlight the importance of elongation fidelity in tissue-specific development.
Mitochondrial diseases
Defects in mitochondrial elongation factors (e.g., GFM1, TUFM) lead to mitochondrial translation disorders with multi-organ phenotypes [1,2]. These conditions underscore the role of elongation in energy metabolism.
From translational elongation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of EEF2 affect elongation rate? | EEF2 knockout cell line |
| Does a point mutation in EEF1A alter codon optimality? | EEF1A1 point-mutation knock-in |
| Where is RNF14 localized during elongation? | RNF14 tagged knock-in (e.g., GFP) |
| Does overexpression of eEF1A drive oncogenic translation? | EEF1A1 overexpression cell model |
| Which genes regulate elongation under stress? | CRISPR library screening with ribosome profiling |
| How does a ribosomal protein mutation affect translation? | RPS19 point-mutation knock-in |
How to Study the translational elongation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy at nucleotide resolution | Genome-wide elongation rate and pausing |
| Single-molecule imaging | Real-time translation dynamics | mRNA localization and stress granule translation [6,7] |
| Polysome profiling | Distribution of mRNAs across ribosomes | Global translation efficiency |
| Mass spectrometry | Protein abundance and modifications | Proteome-wide effects of elongation changes |
| CRISPR knockout screens | Gene essentiality and regulators | Identify elongation modulators |
| CRISPR activation screens | Gene overexpression effects | Discover drivers of translation |
| RNA-seq | mRNA levels and stability | Codon optimality-mediated degradation |
Ribosome profiling (Ribo-seq)
Ribosome profiling provides genome-wide, nucleotide-resolution maps of ribosome occupancy, revealing elongation rates and pausing sites. It is widely used to study codon optimality and mRNA stability.
Single-molecule imaging
Single-molecule imaging in live cells allows real-time visualization of translation dynamics, including elongation of individual mRNA molecules. It has been used to study translation in stress granules.
Proteomics and polysome profiling
Mass spectrometry-based proteomics and polysome profiling quantify protein output and ribosome association, complementing sequencing-based methods [1,5].
CRISPR-based screens
CRISPR knockout and activation screens can identify genes that regulate translational elongation under various conditions, followed by validation with Ribo-seq [4,8].
How CRISPR Can Be Used to Study GO:0006414 translational elongation
Knockout
CRISPR knockout of elongation factors such as EEF2 or EEF1A1 can reveal their essential roles in cell viability and translation [1,2]. Knockout models are used to study loss-of-function phenotypes and compensatory mechanisms.
Point Mutation
Point mutations in GTP-binding domains of EEF2 or EEF1A1 can dissect the mechanistic steps of elongation, such as GTP hydrolysis and translocation. These models are valuable for structure-function studies.
Knock-in
Knock-in of tagged elongation factors (e.g., GFP-EEF2) enables live-cell imaging and proteomic analysis of elongation complexes. Disease-associated mutations in ribosomal proteins can be knocked in to model ribosomopathies.
Overexpression
Overexpression of eEF1A or eEF2 can model oncogenic translation and identify downstream effects on proliferation and stress responses [1,3]. These models are useful for drug screening.
How EDITGENE Supports translational elongation Research
Researchers studying translational elongation-related genes often need to determine whether a candidate gene is causally involved in elongation, mRNA stability, or disease phenotypes. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for translational elongation research.
Frequently Asked Questions About translational elongation
What is GO:0006414 translational elongation?
GO:0006414 is the biological process of successively adding amino acid residues to a nascent polypeptide chain during protein biosynthesis.
What genes are involved in translational elongation?
Key genes include EEF1A1, EEF2, RPL3, RPS19, and mitochondrial factors such as TUFM and GFM1 [1,2,5].
How is translational elongation regulated?
It is regulated by codon optimality, stress kinases like GCN2, mTOR signaling, and quality-control ubiquitylation [1,3,6,8].
What methods study translational elongation?
Ribosome profiling, single-molecule imaging, polysome profiling, and CRISPR screens are commonly used [4,6,7].
Why is translational elongation important in cancer?
Dysregulated elongation supports oncogenic protein synthesis and is a target for therapy [1,3].
What diseases are linked to elongation defects?
Cancer, neurodegeneration, ribosomopathies, and mitochondrial diseases [1,3,5].
How does codon optimality affect elongation?
Codon optimality influences elongation speed and can trigger mRNA degradation.
Can CRISPR be used to study elongation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used [2,5,7].
What is the role of EF-G in elongation?
EF-G catalyzes translocation by converting GTP hydrolysis into ribosome motion.
How does RNF14 relate to elongation?
RNF14-dependent ubiquitylation resolves RNA-protein crosslinks that stall elongation.
Conclusion
Translational elongation (GO:0006414) is a cornerstone of protein biosynthesis, governed by conserved elongation factors and tightly regulated by cellular signals [1,2]. Its dysregulation contributes to cancer, neurodegeneration, and ribosomopathies, making it a critical area of research [3,5]. Advances in ribosome profiling and single-molecule imaging continue to reveal new layers of elongation control [4,7]. EDITGENE's CRISPR services empower researchers to dissect these mechanisms with precision.
References
- 1. Rodnina MV et al.. 2016. Protein Elongation, Co-translational Folding and Targeting.. J Mol Biol 428(10 Pt B):2165-85 PMID: 27038507
- 2. Rodnina MV et al.. 2019. Converting GTP hydrolysis into motion: versatile translational elongation factor G.. Biol Chem 401(1):131-142 PMID: 31600135
- 3. Bae H et al.. 2022. Codon optimality-mediated mRNA degradation: Linking translational elongation to mRNA stability.. Mol Cell 82(8):1467-1476 PMID: 35452615
- 4. Ingolia NT et al.. 2009. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling.. Science 324(5924):218-23 PMID: 19213877
- 5. Ramakrishnan V. 2002. Ribosome structure and the mechanism of translation.. Cell 108(4):557-72 PMID: 11909526
- 6. Mateju D et al.. 2020. Single-Molecule Imaging Reveals Translation of mRNAs Localized to Stress Granules.. Cell 183(7):1801-1812.e13 PMID: 33308477
- 7. Yan X et al.. 2016. Dynamics of Translation of Single mRNA Molecules In Vivo.. Cell 165(4):976-89 PMID: 27153498
- 8. Zhao S et al.. 2023. RNF14-dependent atypical ubiquitylation promotes translation-coupled resolution of RNA-protein crosslinks.. Mol Cell 83(23):4290-4303.e9 PMID: 37951216
